Advertisement

Topics

Takeda and Cardurion announce creation of new cardiovascular development partnership

07:53 EDT 3 Aug 2017 | Topix

Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases.

Original Article: Takeda and Cardurion announce creation of new cardiovascular development partnership

NEXT ARTICLE

More From BioPortfolio on "Takeda and Cardurion announce creation of new cardiovascular development partnership"

Quick Search
Advertisement